Exicure, Inc. (XCUR) Insider Trading Activity

NASDAQ$4.15
Market Cap
$26.45M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
875 of 883
Rank in Industry
503 of 506

XCUR Insider Trading Activity

XCUR Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
0
Sells
$11,579,059
4
100

Related Transactions

SANGSANGIN INVESTMENT & SECURITIES CO., LTD.10 percent owner
0
$0
1
$3.77M
$-3.77M
Exicure HiTron Inc.10 percent owner
0
$0
3
$7.8M
$-7.8M

About Exicure, Inc.

Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease and Angelman syndrome. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.

Insider Activity of Exicure, Inc.

Over the last 12 months, insiders at Exicure, Inc. have bought $0 and sold $11.58M worth of Exicure, Inc. stock.

On average, over the past 5 years, insiders at Exicure, Inc. have bought $5.05M and sold $5.46M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 2,900,000 shares for transaction amount of $8.7M was made by HiTron Systems Inc. (10 percent owner) on 2024‑12‑26.

List of Insider Buy and Sell Transactions, Exicure, Inc.

2026-01-21SaleExicure HiTron Inc.10 percent owner
258,367
2.9708%
$4.50
$1.16M
-33.28%
2026-01-16SaleExicure HiTron Inc.10 percent owner
734,747
8.3398%
$4.50
$3.31M
-32.37%
2026-01-07SaleExicure HiTron Inc.10 percent owner
741,272
8.8254%
$4.50
$3.34M
-26.77%
2025-12-08SaleSANGSANGIN INVESTMENT & SECURITIES CO., LTD.10 percent owner
433,332
11.1099%
$8.71
$3.77M
+0.75%
2024-12-26PurchaseHiTron Systems Inc.10 percent owner
2.9M
19.7564%
$3.00
$8.7M
-55.88%
2024-09-12PurchaseDGP Co., Ltd.10 percent owner
237,223
26.8832%
$3.00
$711,669
+492.48%
2024-02-29SaleDGP Co., Ltd.10 percent owner
3.4M
74.1245%
$1.32
$4.49M
-21.13%
2022-12-15Purchase
CBI USA, Inc.
director
3.4M
–
$1.60
$5.44M
+23.08%
2022-05-19PurchaseMuralidhar Bali
1.47M
1.7441%
$0.19
$285,151
-61.43%
2021-12-21SaleGates Frontier, LLC10 percent owner
1.27M
1.423%
$0.24
$303,200
-53.10%
2021-08-27PurchasePapadimas Elias D.Chief Accounting Officer
10,000
0.0114%
$1.38
$13,800
-86.04%
2020-06-12SaleMirkin Chad A.
10,195
0.012%
$2.83
$28,852
-27.64%
2020-06-12SaleAURASENSE LLC10 percent owner
10,195
0.012%
$2.83
$28,852
-27.64%
2020-03-13PurchaseWALT DAVID Rdirector
291,066
0.3405%
$1.21
$352,859
+77.31%
2020-03-12PurchaseSNYDER DAVID SChief Financial Officer
18,248
0.0224%
$1.40
$25,591
+60.69%
2020-03-12PurchaseMirkin Chad A.
15,000
0.0191%
$1.45
$21,750
+60.69%
2019-12-19PurchaseMuralidhar Balidirector
727,000
0.8229%
$2.75
$2M
-22.94%
2019-08-02PurchaseWALT DAVID Rdirector
1M
1.0487%
$2.00
$2M
-15.25%
2019-08-02PurchaseVenkatesan Jaydirector
250,000
0.2622%
$2.00
$500,000
-15.25%
2019-08-02PurchaseMirkin Chad A.
25,000
0.0262%
$2.00
$50,000
-15.25%
Total: 31
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
Exicure HiTron Inc.10 percent owner
1598947
25.086%
$6.64M13
<0.0001%
SANGSANGIN INVESTMENT & SECURITIES CO., LTD.10 percent owner
0
0%
$001
Mirkin Chad A.
11257629
176.6216%
$46.72M61
+22.72%
AURASENSE LLC10 percent owner
11257629
176.6216%
$46.72M01
Muralidhar Bali
8449126
132.5588%
$35.06M20
<0.0001%
Gates Frontier, LLC10 percent owner
5064703
79.4604%
$21.02M01
WALT DAVID Rdirector
2058777
32.3003%
$8.54M30
<0.0001%
Tompkins Mark N.
1825667
28.643%
$7.58M20
DGP Co., Ltd.10 percent owner
849223
13.3235%
$3.52M11
Venkatesan Jaydirector
302234
4.7418%
$1.25M20
<0.0001%
Jacobs Ian SethPresident, Secretary, CEO, CFO
65000
1.0198%
$269,750.0001
Giljohann David AChief Executive Officer
23666
0.3713%
$98,213.9020
SNYDER DAVID SChief Financial Officer
18248
0.2863%
$75,729.2010
+60.69%
Papadimas Elias D.Chief Accounting Officer
10000
0.1569%
$41,500.0010
<0.0001%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$14,315,062
61
-6.21%
$26.78M
$448,545
49
-21.85%
$17.46M
$6,204,522
45
1.91%
$17.15M
$6,818,859
36
47.81%
$23.64M
$94,610,184
33
-23.48%
$26.7M
$711,440
26
20.43%
$27.07M
$74,023,014
16
-23.35%
$21.62M
$1,091,554
14
-16.96%
$29.39M
$33,809,329
11
-64.88%
$27.83M
$70,584,874
10
3.97%
$21.88M
Exicure, Inc.
(XCUR)
$13,595,542
9
-16.74%
$26.45M
$232,423
8
14.22%
$28.96M
$8,731,108
7
153.66%
$22.43M
$8,470,804
6
-13.28%
$29.1M
$147,504
5
-36.70%
$19.36M
$10,105,079
5
-26.86%
$17.95M
$18,186,879
4
49.41%
$19.92M
$100,266
2
3.17%
$27.78M
$150,000
1
5.48%
$30.2M

XCUR Institutional Investors: Active Positions

Increased Positions5+29.41%12,662+3.23%
Decreased Positions6-35.29%256,482-65.42%
New Positions3New10,707New
Sold Out Positions<1Sold Out10,430Sold Out
Total Postitions16-5.88%148,256-62.19%

XCUR Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Carlyle Group Inc.$1,572.004.69%281,63600%2025-09-30
Vanguard Group Inc$235.000.7%42,044+14,205+51.03%2025-09-30
Geode Capital Management, Llc$164.000.49%29,323+10,360+54.63%2025-09-30
Ubs Group Ag$104.000.31%18,702-7,566-28.8%2025-09-30
Northwestern University$58.000.17%10,43000%2025-09-30
Blackrock, Inc.$32.000.1%5,732+2,682+87.93%2025-09-30
Morgan Stanley$11.000.03%2,055+1,443+235.78%2025-09-30
Tower Research Capital Llc (Trc)$11.000.03%2,032+1,057+108.41%2025-09-30
Bank Of America Corp /De/$0<0.01%44-23-34.33%2025-09-30
Sbi Securities Co., Ltd.$0<0.01%43+9+26.47%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.